The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
miRNA expression as a predictor of survival in patients with metastatic colorectal cancer treated with EGFR inhibitors.
Sandrine Imbeaud
No relevant relationships to disclose
Gilles Manceau
No relevant relationships to disclose
Jean-Baptiste Bachet
No relevant relationships to disclose
Jean-François Emile
No relevant relationships to disclose
Frédéric Bibeau
No relevant relationships to disclose
Marie Danielle Diebold
No relevant relationships to disclose
Charles Marcaillou
Employment or Leadership Position - IntegraGen
Thomas Rio Frio
Employment or Leadership Position - IntegraGen
Delphine Le Corre
No relevant relationships to disclose
Olivier Bouche
No relevant relationships to disclose
Francois Liebaert
Employment or Leadership Position - IntegraGen
Pierre Laurent-Puig
Consultant or Advisory Role - IntegraGen
Research Funding - IntegraGen